Work

A phase IIb, randomized, controlled, multicenter, open-label study of the efficacy and immune response of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously treated metastatic pancreatic adenocarcinoma (ECLIPSE Study).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.3_suppl.tps489

Authors: Dung T. Le, Andrea Wang-Gillam, Vincent J. Picozzi, Todd S. Crocenzi, Michael Morse, Herbert Zeh, Robert Lance Fine, Aimee Murphy, Justin Skoble, Ed Lemmens, Sandy Ferber, Allan Rosen, John J. Grous, Thomas Dubensky, Dirk G. Brockstedt, Eric Lutz, Elizabeth M. Jaffee

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Washington University in St. Louis, Virginia Mason Medical Center, Providence Portland Medical Center, Duke Medical Center, University of Pittsburgh Medical Center, Columbia University, Aduro BioTech (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589976327

Cites:

Cited by: 2

Related to: 10